A single CRISPR infusion lowers blood fats in monkeys for three years

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

High levels of LDL cholesterol and triglycerides, which are types of blood fats, are major contributors to atherosclerotic cardiovascular disease. Gene-editing technologies offer a potential alternative to lipid-lowering medications. In a new CRISPR experiment, a single infusion of a gene-editing treatment kept triglyceride levels low in monkeys for three years. The findings support the…

Read original article on Medical Xpress - latest medical and health news stories →

Related news